Mpox: AfricaCDC and Bavarian Nordic partner to deliver 10M vaccine doses by 2025

AfricaCDC disclosed: “@AfricaCDC and 

@BavarianNordic are partnering to deliver 10M Mpox vaccine doses by 2025, with up to 2M this year. This effort ensures equitable access following the Mpox PHECS.”

'Mpox Vaccine'
‘Mpox Vaccine’. Photo: @AfricaCDC

According to bavarian-nordic.com:

BAVARIAN NORDIC PROVIDES STATEMENT ON MPOX VACCINE SUPPLY AND COLLABORATION WITH AFRICAN AND GLOBAL STAKEHOLDERS

Bavarian Nordic A/S (OMX: BAVA) provides an update on plans for securing supply of vaccines to tackle the current mpox outbreak that the Africa Centers for Disease Control and Prevention (Africa CDC) declared as a Public Health Emergency of Continental Security (PHECS) on August 13, 2024 followed by the World Health Organization (WHO) that declared mpox as a Public Health Emergency of International Concern (PHEIC) on August 14, 2024.

“Bavarian Nordic is working closely with all stakeholders to ensure the equitable access to our mpox vaccine during the current PHECS and PHEIC. Importantly, we have built a strong partnership with the Africa CDC, both on supply, but also expanding our manufacturing network to include Africa. We are also working with the WHO on a regulatory path to ensure access to all countries, while in parallel seeking approval for use in adolescents and conducting clinical studies in Africa to further expand the use to children. We are prepared to work with the Africa CDC and the international community to play our role in protecting and saving lives around the World and to contain the latest outbreak,” said Paul Chaplin, President & CEO of Bavarian Nordic.

Since 2022, Bavarian Nordic has created a vaccine inventory to provide a surge capacity for potential outbreaks. In response to recent events, the company also plans to ramp-up vaccine manufacturing to ensure the continued equitable access to the mpox vaccine. Consequently, the company has informed the Africa CDC that it has the capacity to manufacture 10 million doses by the end of 2025, in addition to current orders, and could already supply up to 2 million doses this year.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *